Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
20.67
-0.08 (-0.39%)
At close: Feb 26, 2026, 4:00 PM EST
20.56
-0.11 (-0.53%)
After-hours: Feb 26, 2026, 7:37 PM EST
Syndax Pharmaceuticals Market Cap
Syndax Pharmaceuticals has a market cap or net worth of $1.8 billion as of February 26, 2026. Its market cap has increased by 39.10% in one year.
Market Cap
1.80B
Enterprise Value
1.69B
1-Year Change
39.10%
Ranking
Category
Stock Price
$20.67
Market Cap Chart
Since March 3, 2016, Syndax Pharmaceuticals's market cap has increased from $208.60M to $1.80B, an increase of 761.23%. That is a compound annual growth rate of 24.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 1.80B | -1.24% |
| Dec 31, 2025 | 1.83B | 61.83% |
| Dec 31, 2024 | 1.13B | -25.02% |
| Dec 29, 2023 | 1.50B | -1.81% |
| Dec 30, 2022 | 1.53B | 41.76% |
| Dec 31, 2021 | 1.08B | 18.96% |
| Dec 31, 2020 | 908.90M | 281.41% |
| Dec 31, 2019 | 238.30M | 115.66% |
| Dec 31, 2018 | 110.50M | -48.29% |
| Dec 29, 2017 | 213.70M | 63.88% |
| Dec 30, 2016 | 130.40M | -37.49% |
| Mar 3, 2016 | 208.60M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Galecto | 1.84B |
| Sarepta Therapeutics | 1.83B |
| Novavax | 1.82B |
| Pharvaris | 1.82B |
| RAPT Therapeutics | 1.79B |
| Tyra Biosciences | 1.78B |
| Zymeworks | 1.78B |
| Enliven Therapeutics | 1.76B |